Faricimab

What it is used for

VABYSMO is a vascular endothelial growth factor (VEGF) and angiopoietin 2 (Ang-2) inhibitor indicated for the treatment of patients with:

Side effects, and when to stop

The following potentially serious adverse reactions are described elsewhere in the labeling:

• Hypersensitivity
• Endophthalmitis and retinal detachments
• Increase in intraocular pressure
• Thromboembolic events
• Retinal Vasculitis and/or Retinal Vascular Occlusion

Storing it

Store VABYSMO in the refrigerator between 2°C to 8°C (36°F to 46°F). Do not freeze. Do not shake. Keep the sealed tray containing the prefilled syringe or the vial in the original carton to protect from light.

Prior to use, the unopened prefilled syringe or glass vial of VABYSMO may be kept at room temperature, 20°C to 25°C (68°F to 77°F), for up to 24 hours. Ensure that the injection is given immediately after preparation of the dose.